Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Bladder Cancer

  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 60 articles:
HTML format

Single Articles

    April 2021
  1. CHEN X, Chen S
    LINC00649 promotes bladder cancer malignant progression by regulating the miR15a5p/HMGA1 axis.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

    March 2021
  2. JIA M, Su B, Mo L, Qiu W, et al
    Circadian clock protein CRY1 prevents paclitaxelinduced senescence of bladder cancer cells by promoting p53 degradation.
    Oncol Rep. 2021;45:1033-1043.
    PubMed     Abstract available

  3. CHOU KY, Chang AC, Tsai TF, Lin YC, et al
    MicroRNA34a5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase2 silencing.
    Oncol Rep. 2021;45:911-920.
    PubMed     Abstract available

    January 2021
  4. LI S, Zhao Y, Chen X
    Microarray expression profile analysis of circular RNAs and their potential regulatory role in bladder carcinoma.
    Oncol Rep. 2021;45:239-253.
    PubMed     Abstract available

    November 2020
  5. CHEN Y, Xu T, Xie F, Wang L, et al
    Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7853.
    PubMed     Abstract available

  6. ZHANG Z, Chen F, Zhan H, Chen L, et al
    lncRNA CASC9 sponges miR7583p to promote proliferation and EMT in bladder cancer by upregulating TGFbeta2.
    Oncol Rep. 2020 Nov 13. doi: 10.3892/or.2020.7852.
    PubMed     Abstract available

  7. SHEN C, Wang Y, Wu Z, Da, et al
    Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
    Oncol Rep. 2020;44:1831-1850.
    PubMed     Abstract available

    April 2020
  8. VALLO S, Stege H, Berg M, Michaelis M, et al
    Tumor necrosis factorrelated apoptosisinducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against firstline chemotherapy.
    Oncol Rep. 2020;43:1331-1337.
    PubMed     Abstract available

    February 2020
  9. LIU J, Zhao Z, Sun Z, Liu C, et al
    Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.
    Oncol Rep. 2020;43:562-570.
    PubMed     Abstract available

    December 2019
  10. YIN H, Zhang C, Gou X, He W, et al
    Identification of a 13mRNA signature for predicting disease progression and prognosis in patients with bladder cancer.
    Oncol Rep. 2019 Dec 12. doi: 10.3892/or.2019.7429.
    PubMed     Abstract available

    September 2019
  11. JOU YC, Wang SC, Dai YC, Chen SY, et al
    Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells.
    Oncol Rep. 2019;42:1005-1016.
    PubMed     Abstract available

    August 2019
  12. LI F, Guo H, Yang Y, Feng M, et al
    Autophagy modulation in bladder cancer development and treatment (Review).
    Oncol Rep. 2019 Aug 21. doi: 10.3892/or.2019.7286.
    PubMed     Abstract available

    July 2019
  13. TOLLE A, Buckendahl L, Jung K
    Plasma miR15b5p and miR5905p for distinguishing patients with bladder cancer from healthy individuals.
    Oncol Rep. 2019 Jul 24. doi: 10.3892/or.2019.7247.
    PubMed     Abstract available

  14. WANG F, Li Y, Shan F, Zhang Q, et al
    Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG.
    Oncol Rep. 2019 Jul 23. doi: 10.3892/or.2019.7246.
    PubMed     Abstract available

    June 2019
  15. XUE Y, Tong L, LiuAnwei Liu F, Liu A, et al
    Tumorinfiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer.
    Oncol Rep. 2019 Jun 12. doi: 10.3892/or.2019.7196.
    PubMed     Abstract available

    May 2019
  16. SUN X, Song J, Li E, Geng H, et al
    ()Epigallocatechin3gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
    Oncol Rep. 2019 May 24. doi: 10.3892/or.2019.7170.
    PubMed     Abstract available

    March 2019
  17. CHENG H, Hao Y, Gao Y, He Y, et al
    PLCepsilon promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathwaymediated glycolysis.
    Oncol Rep. 2019 Mar 13. doi: 10.3892/or.2019.7056.
    PubMed     Abstract available

  18. HORI S, Miyake M, Tatsumi Y, Morizawa Y, et al
    Intravesical treatment of chemotherapeutic agents sensitizes bacillus CalmetteGuerin by the modulation of the tumor immune environment.
    Oncol Rep. 2019;41:1863-1874.
    PubMed     Abstract available

    February 2019
  19. SEKINO Y, Sakamoto N, Ishikawa A, Honma R, et al
    Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7039.
    PubMed     Abstract available

  20. ZHUO Z, Song Z, Ma Z, Zhang Y, et al
    Chlorophyllin e6mediated photodynamic therapy inhibits proliferation and induces apoptosis in human bladder cancer cells.
    Oncol Rep. 2019 Feb 14. doi: 10.3892/or.2019.7013.
    PubMed     Abstract available

  21. HO JN, Byun SS, Lee SE, Youn JI, et al
    Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatinresistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
    Oncol Rep. 2019 Feb 11. doi: 10.3892/or.2019.7005.
    PubMed     Abstract available

    December 2018
  22. JING J, Liu J, Wang Y, Zhang M, et al
    The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6937.
    PubMed     Abstract available

  23. LI F, Sun Y, Jia J, Yang C, et al
    Silibinin attenuates TGFbeta1induced migration and invasion via EMT suppression and is associated with COX2 downregulation in bladder transitional cell carcinoma.
    Oncol Rep. 2018;40:3543-3550.
    PubMed     Abstract available

    November 2018
  24. ZHANG J, Mao S, Wang L, Zhang W, et al
    MicroRNA154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7.
    Oncol Rep. 2018 Nov 21. doi: 10.3892/or.2018.6879.
    PubMed     Abstract available

  25. LIU CP, Zhang JH, Zheng SC, Liu J, et al
    A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
    Oncol Rep. 2018;40:2826-2835.
    PubMed     Abstract available

  26. LEBRUN L, Milowich D, Le Mercier M, Allard J, et al
    UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
    Oncol Rep. 2018;40:2497-2506.
    PubMed     Abstract available

    October 2018
  27. WANG P, Zhang Y, Zhang J, Jiang J, et al
    IL23 concentrationdependently regulates T24 cell proliferation, migration and invasion and is associated with prognosis in patients with bladder cancer.
    Oncol Rep. 2018 Oct 8. doi: 10.3892/or.2018.6775.
    PubMed     Abstract available

    September 2018
  28. WU K, Mu XY, Jiang JT, Tan MY, et al
    miRNA26a5p and miR26b5p inhibit the proliferation of bladder cancer cells by regulating PDCD10.
    Oncol Rep. 2018 Sep 26. doi: 10.3892/or.2018.6734.
    PubMed     Abstract available

    August 2018
  29. XU ZL, Zhang Y, Wang L, Li F, et al
    B7H3 promotes malignant progression of muscleinvasive bladder cancer.
    Oncol Rep. 2018 Aug 17. doi: 10.3892/or.2018.6655.
    PubMed     Abstract available

  30. GAO F, Wang X, Chen S, Xu T, et al
    CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6641.
    PubMed     Abstract available

    July 2018
  31. ZHANG H, Qi D, Li J, Peng T, et al
    A novel regulatory circuit of miR152 and DNMT1 in human bladder cancer.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6553.
    PubMed     Abstract available

  32. ZHANG T, Yang F, Li W, Liu B, et al
    Suppression of the SDF1/CXCR4/betacatenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
    Oncol Rep. 2018 Jul 4. doi: 10.3892/or.2018.6546.
    PubMed     Abstract available

    May 2018
  33. LI WL, Yu HY, Zhang XJ, Ke M, et al
    Purple sweet potato anthocyanin exerts antitumor effect in bladder cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6421.
    PubMed     Abstract available

    April 2018
  34. CHEN D, Xu J, Zhang Q
    Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
    Oncol Rep. 2018 Apr 5. doi: 10.3892/or.2018.6359.
    PubMed     Abstract available

  35. XIAO J, Niu S, Zhu J, Lv L, et al
    miR223p enhances multichemoresistance by targeting NET1 in bladder cancer cells.
    Oncol Rep. 2018 Apr 4. doi: 10.3892/or.2018.6355.
    PubMed     Abstract available

    March 2018
  36. LIU X, Kong C, Zhang Z
    miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Oncol Rep. 2018 Mar 6. doi: 10.3892/or.2018.6300.
    PubMed     Abstract available

  37. LIU S, Jiang H, Wen H, Ding Q, et al
    Knockdown of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ) enhances tumorigenesis both in vivo and in vitro in bladder cancer.
    Oncol Rep. 2018 Mar 5. doi: 10.3892/or.2018.6294.
    PubMed     Abstract available

    January 2018
  38. MA J, Ge J, Xue X, Xiu W, et al
    Targeting bladder cancer using activated T cells armed with bispecific antibodies.
    Oncol Rep. 2018 Jan 11. doi: 10.3892/or.2018.6211.
    PubMed     Abstract available

    December 2017
  39. TAKAMURA T, Horinaka M, Yasuda S, Toriyama S, et al
    FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells.
    Oncol Rep. 2017 Dec 1. doi: 10.3892/or.2017.6127.
    PubMed     Abstract available

    September 2017
  40. ZHAO X, Ji Z, Xie Y, Liu G, et al
    MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5992.
    PubMed     Abstract available

  41. KOU B, Liu W, Xu X, Yang Y, et al
    Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5988.
    PubMed     Abstract available

  42. HUANG B, Zhang J, Zhang X, Huang C, et al
    Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5959.
    PubMed     Abstract available

    August 2017
  43. TSUJITA Y, Horiguchi A, Tasaki S, Isono M, et al
    STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Oncol Rep. 2017 Aug 11. doi: 10.3892/or.2017.5902.
    PubMed     Abstract available

  44. GAO SL, Kong CZ, Zhang Z, Li ZL, et al
    TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5883.
    PubMed     Abstract available

    July 2017
  45. WANG SC, Wang ST, Liu HT, Wang XY, et al
    Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1survivin downregulation at the late phase of treatment.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5795.
    PubMed     Abstract available

    June 2017
  46. WANG S, Liu B, Zhang J, Sun W, et al
    Centromere protein U is a potential target for gene therapy of human bladder cancer.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5769.
    PubMed     Abstract available

  47. WANG H, Zhong J, Wu C, Liu Y, et al
    Stromal antigen 2 functions as a tumor suppressor in bladder cancer cells.
    Oncol Rep. 2017 Jun 12. doi: 10.3892/or.2017.5711.
    PubMed     Abstract available

  48. RADY M, Mostageer M, Rohde J, Zaghloul A, et al
    Therapy-relevant aberrant expression of MRP3 and BCRP mRNA in TCC-/SCC-bladder cancer tissue of untreated patients.
    Oncol Rep. 2017 Jun 2. doi: 10.3892/or.2017.5695.
    PubMed     Abstract available

    May 2017
  49. BA M, Cui S, Wang B, Long H, et al
    Bladder intracavitary hyperthermic perfusion chemotherapy for the prevention of recurrence of non-muscle invasive bladder cancer after transurethral resection.
    Oncol Rep. 2017;37:2761-2770.
    PubMed     Abstract available

    April 2017
  50. YUAN SY, Shiau MY, Ou YC, Huang YC, et al
    Miconazole induces apoptosis via the death receptor 5-dependent and mitochondrial-mediated pathways in human bladder cancer cells.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5608.
    PubMed     Abstract available

  51. WU D, Niu X, Tao J, Li P, et al
    MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2.
    Oncol Rep. 2017 Apr 27. doi: 10.3892/or.2017.5607.
    PubMed     Abstract available

    March 2017
  52. LI W, Liu J, Zou D, Cai X, et al
    Exploration of bladder cancer molecular mechanisms based on miRNA-mRNA regulatory network.
    Oncol Rep. 2017;37:1461-1468.
    PubMed     Abstract available

    January 2017
  53. CHEN JF, Yu BX, Yu R, Ma L, et al
    Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis.
    Oncol Rep. 2017 Jan 5. doi: 10.3892/or.2017.5356.
    PubMed     Abstract available

    December 2016
  54. YU G, Jia Z, Dou Z
    miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Oncol Rep. 2016 Dec 16. doi: 10.3892/or.2016.5326.
    PubMed     Abstract available

    October 2016
  55. COCCIA A, Mosca L, Puca R, Mangino G, et al
    Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5150.
    PubMed     Abstract available

  56. HORI S, Miyake M, Onishi S, Tatsumi Y, et al
    Clinical significance of alpha and betaKlotho in urothelial carcinoma of the bladder.
    Oncol Rep. 2016;36:2117-25.
    PubMed     Abstract available

    September 2016
  57. ZHANG Y, Zhang Z, Li Z, Gong D, et al
    MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3.
    Oncol Rep. 2016;36:1293-300.
    PubMed     Abstract available

    August 2016
  58. ZHANG N, Bi X, Zeng Y, Zhu Y, et al
    TGF-beta1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
    Oncol Rep. 2016;36:977-83.
    PubMed     Abstract available

    July 2016
  59. YANG X, Zhang F, Luo J, Pang J, et al
    A new non-muscle-invasive bladder tumor-homing peptide identified by phage display in vivo.
    Oncol Rep. 2016;36:79-89.
    PubMed     Abstract available

    May 2016
  60. DENG QF, Sun X, Liang ZF, Zhang ZQ, et al
    Cigarette smoke extract induces the proliferation of normal human urothelial cells through the NF-kappaB pathway.
    Oncol Rep. 2016;35:2665-72.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.